Krox-24 (NGFI-A, Egr-1) is an immediate-early gene encoding a zinc ®nger transcription factor. As Krox-24 is expressed in brain areas showing post-natal neurogenesis during a thyroid hormone (T 3 )-sensitive period, we followed T 3 eects on Krox-24 expression in newborn mice. We analysed whether regulation was associated with changes in mitotic activity in the subventricular zone and the cerebellum. In vivo T 3 -dependent Krox-24 transcription was studied by polyethylenimine-based gene transfer. T 3 increased transcription from the Krox-24 promoter in both areas studied at post-natal day 2, but was without eect at day 6. An intact thyroid hormone response element (TRE) in the Krox-24 promoter was necessary for these inductions. These stage-dependent eects were also seen in endogenous Krox-24 mRNA levels: activation at day 2 and no eect at day 6. Moreover, similar results were obtained by examining bgalactosidase expression in heterozygous mice in which one allele of the Krox-24 gene was disrupted with an inframe Lac-Z insertion. However, bromodeoxyuridine incorporation showed mitosis to continue through to day 6. We conclude ®rst, that T 3 activates Krox-24 transcription during early post-natal mitosis but that this eect is extinguished as development proceeds and second, loss of T 3 -dependent Krox-24 expression is not correlated with loss of mitotic activity.
Introduction
In vertebrates, thyroid hormone 3,5,3'-triiodothyronine (T 3 ) is an important regulator of central nervous system (CNS) development. T 3 acts principally at the transcriptional level to dierentially modulate neuronal and glial cell gene expression at dierent stages of development and during adulthood (for review see Lebel and Dussault, 1994) . Many of the T 3 -responsive genes regulated during development could be implicated in determining the critical balance between proliferation and apoptosis in the CNS (Rohrer, 1990) . One gene that could play a key role in this equilibrium is the Krox-24 gene.
The Krox-24 gene (also known as NGFI-A, egr-1, zif-268, TIS-8, and CEF-5 encodes a transcription factor which contains three zinc ®ngers of the C2H2 subtype (for review see Gashler and Sukhatme, 1995) . It was originally identi®ed as an early immediate gene (EIG) induced in ®broblasts by dierent mitogens (Sukhatme et al., 1987) and during Nerve Growth Factor induction of PC12 dierentiation (Milbrandt, 1987) . A number of observations support the concept that the gene is a good candidate for mediating T 3 action on post-natal mitotic activity in the mammalian brain. First, Krox-24 is rapidly activated in vitro by mitogenic stimulation, membrane depolarization and synaptic activity in a number of cell types (Christy and Nathans, 1989; Lemaire et al., 1988; . Second, it has been shown that Krox-24 mRNA expression is aected by thyroid status in the developing rat brain (MellstroÈ m et al., 1994; Pipaon et al., 1992) . However, one main argument against the gene being directly implicated in regulation of mitotic activity in the brain came from examination of the phenotype of Krox-24 7/7 null mice (Lee et al., 1995 (Lee et al., , 1996 Topilko et al., 1997) . Although dierent approaches, either with (Topilko et al., 1997) or without (Lee et al., 1995 (Lee et al., , 1996 a bgalactosidase in-frame insertion, were used to produce null alleles, in both cases these 7/7 null mice showed no obvious modi®cations in cell numbers in the CNS (Lee et al., 1995 (Lee et al., , 1996 Topilko et al., 1997) . However, the number of neurons and glia in the mature nervous system results from a balance between proliferation and cell death (Ra, 1992) and T 3 can aect both processes in the developing CNS (Ghorbel et al., 1997) . Thus, we looked more closely at T 3 eects on Krox-24 expression during mitosis in two brain areas where post-natal neurogenesis and gliogenesis occur: the subventricular zone (Luskin, 1993) and the cerebellum (Nicholson and Altman, 1972) . We asked two questions: ®rst, whether T 3 -eects on Krox-24 expression involved transcriptional regulation and second, whether this regulatory activity was correlated with mitotic activity. We focused on the ®rst postnatal week because, the rodent brain develops and matures rapidly after birth, and it is during this period that eects of thyroid hormone de®ciency are most apparent. To analyse whether any of the T 3 eects were played out at the transcriptional level we used somatic gene transfer and germinal transgenesis. We found that T 3 did stimulate transcription of the Krox-24 gene on the second postnatal day (P2), but was without eect at P6. However, these temporally distinct eects were not correlated with changes in mitotic activity. Bromodeoxyuridine (BrdU) labelling showed DNA synthesis to continue similarly in both areas examined throughout the ®rst post-natal week. We conclude that although T 3 induction of Krox-24 transcription is abrogated as development proceeds, this loss of Krox-24 activity does not implicate loss of mitotic activity.
Results
T 3 regulates Krox-24 expression at the transcriptional level in the newborn mouse brain Our ®rst question was whether the T 3 eects on Krox-24 mRNA expression already described in other mammals (MellstroÈ m et al., 1994; Pipaon et al., 1992) were played out at the transcriptional level. To this end we applied a recently developed non-viral gene transfer technique based on the condensation of DNA by polyethylenimine (PEI; Abdallah et al., 1996; Boussif et al., 1995) . First, we tested the validity of our approach by quantifying the correlation between the expression of two constitutively expressed genes co-injected into the same brain area. This was a prerequisite to using a co-injected ubiquitously expressed gene (CMV-CAT) to normalize for expression from a physiologically regulated transgene, in this instance 1393 bp of the mouse Krox-24 promoter (Krox-24-luc). As shown in Figure 1a , luciferase and CAT expressions from two plasmids driven by CMV promoter sequences were well correlated (R=0.82). We then used this approach to test T 3 eects on Krox-24-luc transcription in the subventricular zone (SVZ) and cerebellum (CB) at P2 and P6.
Thyroidectomised (Tx) pups were used to avoid interference from endogenous T 3 on these short-term transcriptional responses. To verify that the chemical thyroidectomy was ecient we used a radioimmunoassay (Demeneix and Henderson, 1978) to measure the plasma T 4 and T 3 levels in plasma of P2 and P6 mice. In controls T 3 and T 4 levels were respectively 34.9+18 pg/ ml and 11+0.8 ng/ml on P2 and respectively 452+106 pg/ml and 32.2+3.1 ng/ml on P6. PTU treatment rendered the pups hypothyroid, as PTUtreated pups had very low levels of T 4 at both P2 and P6 (respectively 2.2+0.2 ng/ml and 0.2+0.2 ng/ml). These values were signi®cantly lower than controls (P50.001, Student's t-test). The levels of T 3 in these animals were below the level of sensitivity of the assay (25 pg/ml).
As shown in Figure 1b , in P2 Tx pups, T 3 treatment induced 80 and 110% increases in transcription from the Krox-24 promoter introduced into the SVZ and CB respectively. These increases were highly signi®cantly (P50.01 in each case). To determine that the eect was exerted through the thyroid hormone response element (TRE) in the Krox-24 promoter (from bases 7971 ± 7956 upstream of the transcription start site) we carried out site directed mutagenesis and used the mutated clone in the in vivo gene transfer assay. T 3 no longer exerted any transcriptional eect on this mutated promoter, underlining the molecular basis of the transcriptional eect of T 3 through the consensus TRE.
Transcriptional regulation of Krox-24 in the newborn mouse brain is dependent on developmental stage
We next examined T 3 eects on transcription from the Krox-24 promoter at later stages of development. At P6, responses were quite dierent from those seen at P2 in that no T 3 eect on Krox-24 transcription was found in either brain region at this developmental stage ( Figure 2a) . As a matter of interest we then checked whether T 3 would aect transcription from a concensus TREpal in these areas at this time point. We found that although T 3 signi®cantly enhanced transcription Figure 1 (a) Correlation between luciferase and CAT activities following PEI-based in vivo gene transfer in the newborn mouse brain. Plasmids (0.35 mg pCMV-luc and 0.15 mg pCMV-CAT in 2 ml 5% glucose) were complexed with PEI 22 kDa (4 eq) and injected into the subventricular zone (SVZ). After 17 h, P2 mice were anesthetized, decapitated and tissues removed for luciferase and CAT assays. (b) T 3 regulates Krox-24 expression at the transcriptional level in both the SVZ and the cerebellum (CB) through a consensus TRE. Plasmids (0.75 mg of control (left hand columns) or mutated (right hand columns) Krox-24-luc and 0.15 mg pCMV-CAT per injection) in 2 ml 5% glucose were complexed with PEI 22 kDa (at 4 eq) and injected in the SVZ or the CB of hypothyroid P2 mice. After 17 h, mice were anesthetized and decapitated. Tissues were analysed for luciferase and CAT activities. T 3 (or saline control) was injected 3 h before sacri®ce. Means+s.e.m. are given, n510. See Materials and methods for sequences of control and mutated Krox-24-luc from this promoter in the CB (P50.05), no T 3 -dependent transcriptional eects were observed in the SVZ (Figure 2b ). At P2, T 3 -dependent transcriptional eects were observed from the TRE in both the SVZ and the CB (data not shown).
T 3 regulates endogenous Krox-24 expression
To examine whether the eects on Krox-24 transcription were parallel with regulation of the endogenous gene, we extracted total RNA from the SVZ and CB of hypothyroid (Tx), normal mice and normal mice injected with T 3 prior to sacri®ce. Krox-24 mRNA levels were compared in pools of tissue dissected from these groups at P2 and P6. As shown in Figure 3 , Krox-24 mRNA expression is reduced in the SVZ and CB of Tx animals at P2. However, treatment of normal animals with T 3 does not reveal any further increase in Krox-24 mRNA. At P6 the situation is markedly dierent (Figure 3 ). On the one hand, in the SVZ Krox-24 expression is maintained, but hypothyroidism is no longer inhibitory. On the other hand, in the CB, no expression is found in controls nor in T 3 -treated animals. However, residual expression is found in the Tx group.
b-galactosidase expression in mice bearing an in-frame insertion of b-galactosidase in the Krox-24 sequence shows similar developmental and T 3 -dependent regulations
As a complement to the somatic gene transfer approach and Northern blotting we also examined the eects of T 3 on b-galactosidase activity in a mouse line in which the lacZ gene has been inserted into one Figure 2 (a) Krox-24 transcription in vivo is unaected by T 3 in late brain development. Plasmids (0.75 mg Krox-24-luc and 0.15 mg pCMV-CAT per injection) in 2 ml 5% glucose were complexed with PEI 22 kDa (at 4 eq) and injected into the subventricular zone (SVZ) or the cerebellum (CB) of hypothyroid P5 mice. After an interval of 17 h, mice were anesthetized and decapitated. The tissues were removed for luciferase and CAT assays. T 3 (or saline control) was injected 3 h before sacri®ce. (b) Transcription from a TREpal element in vivo is tissue dependent during late brain development. Note that normalized luciferase activity is unaected by T 3 in the SVZ but stimulated in CB following gene transfer into brains of P6 mice. Plasmids (0.2 mg TRE-luc and 0.15 mg pCMV-CAT in 2 ml 5% glucose) were complexed with PEI 22 kDa (4 eq) and injected in SVZ or CB of hypothyroid P5 mice. Other details as in (a). Means+s.e.m. are given, n510 Figure 3 Expression of endogenous Krox-24 gene in the subventricular zone (SVZ) and cerebellum (CB) of normal, hypothyroid (Tx), and euthyroid T 3 -treated newborn mice. Upper ®gure: Normalized Krox-24 expression (Krox-24/b-actin signals measured by PhosphorImager scanning) from normal (N), hypothyroid (Tx), and euthyroid T 3 -treated (+T 3 ) 2 and 6 dayold mice. Lower ®gure: representative Northern blot analysis of total RNA (40 mg) extracted from normal (N), hypothyroid (Tx), and euthyroid T 3 -treated (+T 3 ) 2 and 6 day-old mice. Upper blot: A 0.7 kb fragment from the mouse Krox-24 cDNA was used as a hybridization probe. Lower blot: Same blot hybridized with a 1 kb fragment from the mouse b-actin cDNA, used as a control allele of the Krox-24 locus by homologous recombination. In these heterozygous Krox-24 +/7 animals, the bona ®de b-galactosidase is synthesized and its expression re¯ects the normal Krox-24 expression pattern in the tissues analysed (Topilko et al., 1997) . No abnormal phenotype has been observed when the animals are heterozygous for this mutation. The observations on endogenous expression and T 3 regulation of Krox-24 expression in these animals bolstered the key results already obtained by the other two experimental methods. First, b-galactosidase activity was found in the CB of untreated pups at P2 but not at P6 (Figure 4) . Second, b-galactosidase activity was found in the SVZ at both P2 (Figure 5a ) and P6 (data not shown). Third, T 3 -treatment induced b-galactosidase activity in the SVZ on P2 (Figure 5b ). It is noteworthy that in the SVZ this induction was localized to cells of the striatal SVZ (arrows in Figure  5a and b). A T 3 -dependent induction was also seen in the CB (data not shown). Figure 5c shows that the PEI-based somatic gene transfer injection targets transgene expression (in this case CMV-b-galactosidase) to this same area in wild type mice. This provides Figure 4 b-galactosidase expression in the cerebellum of Krox-24 +/7 mice at P2 (a) and P6 (b). b-galactosidase activity was found at P2 but not at P6. Pups at the given post natal day were decapitated and brains were removed then ®xed overnight in toto. Vibratome sections (100 mm) were immersed 3 h in b-Gal revelation solution at 338C and counterstained with eosin/ haemetoxylin. A blue precipitate was only seen in brains of Krox-24 +/7 heterozygous mice. No staining was seen in brains of wild type mice. Magni®cation a and b: 6120 an anatomical support for the similarity of the results obtained by the two methods: germinal and somatic transgenesis.
BrdU incorporation shows mitotic activity to continue through to P6
To examine whether the losses of Krox-24 expression and T 3 -dependent induction were correlated with a reduction in mitotic activity, we followed BrdU incorporation in the two brain areas with BrdU immunocytochemistry. As shown in Figure 6 high, and equivalent, levels of DNA synthesis are found on P2 and P6 in the CB. Similar results were obtained for the SVZ (data not shown). Thus, the spatio-temporal variations in Krox-24 expression and T 3 -dependent regulation, seen with each experimental approach, are not related to changes in mitotic activity in these areas.
Discussion
T 3 stimulates Krox-24 expression at the transcriptional level in a developmentally de®ned manner
The problem of how T 3 exerts its eects in the development CNS can be placed in the more general context of how stage-speci®c and cell-speci®c responses arise from uniquitous signals. In the case of T 3 -induced responses, current thinking identi®es a number of key players. These include a variety of thyroid hormone receptor (TR) isoforms which, combined with heterodimeric partners, allows recognition of dierent core motifs (TREs) within the promoters of target genes (Glass, 1994) . A further level of complexity is brought about the protein/protein interactions that can occur between the receptors themselves and with other transcription factors or accessory proteins (Wole, 1997) . The transcriptional response of a cell to a given signal will be a function of its history and how the signals received during development have aected the resulting pro®le of nuclear proteins produced. Thus, ideally, analysis of stage-speci®c transcriptional regulation is best carried out in the whole animal where the developmental and spatial inputs impinging on a cell are operating in their normal physiological context. A good way of analysing developmental changes in an integrated context is somatic gene transfer, on condition that it is suciently ecient.
Following this line of thinking we used a novel PEIbased gene transfer method (Abdallah et al., 1996; Boussif et al., 1995) to introduce a Krox-24-luciferase construct into areas of postnatal CNS neurogenesis (Luskin, 1993; Nicholson and Altman, 1972) . We show that T 3 stimulates transcription from the Krox-24 promoter at P2, but not at P6 in these areas. Searching for a TRE in the promoter sequence of the mouse Krox-24 promoter (Tsai-Morris et al., 1988) revealed one near-perfect DR4 (AGGTCC CCAA AGGTGG) between bases 7971 and 7956 upstream of the transcription start site. This provides a good molecular basis for a site of interaction with a TR and its heterodimeric partner, RXR (Glass, 1994) . Other putative, less classical sites include a DR2 between bases 7655 and 7642, and a DR5 between bases 7756 and 7740. Some half sites also are present within the ®rst 900 bp. However, mutating just the DR4, between bases 7971 and 7956, showed that this site was both sucient and necessary for mediating the transcriptional eects of T 3 on Krox-24 transcription.
Not only do these results show that transcriptional regulation of the gene by T 3 is a developmentally regulated process, but they also ®t well with our data obtained by Northern blotting, which in turn corroborate results obtained in the newborn rat (MellstroÈ m et al., 1994) . In hypothyroid rats Krox-24 mRNA is dierentially reduced depending on the brain area and developmental stage. Moreover, in the rat, reduced mRNA levels are restored either by T 3 treatment or spontaneously during development (MellstroÈ m et al., 1994) . This again ®ts with our data in hypothyroid mice at P6, where there are no dierences with the normal controls. Thus, at P2, thyroid hormone activates the accumulation of Krox-24 mRNA, whereas at P6 there are no longer any T 3 -dependent eects.
These developmental eects could possibly be related to changes in expression of dierent TR isoforms that can in some cases have dierential eects on neuronal gene transcription (Guissouma et al., in press; Lezoualc'h et al., 1992) . Indeed, data obtained by in situ hybridization in the newborn rat show that both TRa1 and TRa2 mRNAs are Figure 6 BrdU immunocytochemistry shows similar mitotic activity on P2 (a) and P6 (b) in the cerebellum. Wild type pups were injected with BrdU. After 1 h animals were sacri®ced, brains removed and ®xed. BrdU incorporation was detected by immunocytochemistry using monoclonal mouse anti-BrdU antibody and a goat peroxidase-conjugated second antibody. Cells that had incorporated BrdU had a brown nuclear signal, seen here as black. Magni®cation a and b: 6400 upregulated during the ®rst postnatal week (Bradley et al., 1992) . As TRa2 is a non-T 3 binding isoform that blocks T 3 -dependent transcriptional activation (Koenig et al., 1989) , it is possible that high levels of TRa2 protein could be implicated in blocking the Krox-24 response to T 3 at P6. However, for this to be the case there would need to be a particular con®guration of the DR4 TRE in the Krox-24 promoter that favors interaction with this repressive isoform. This is because transcription from a palindromic TRE introduced into the cerebellum at P6 can still be activated by T 3 , whereas transcription from the Krox-24 promoter cannot be activated. Another possibility is that at P6 there is increased expression of an inhibitory transcription factor that binds speci®cally to the Krox-24 promoter and overrides the T 3 stimulation. A good candidate could be c-Fos, which has been shown to repress transcription from the Krox-24 promoter in vitro (Gius et al., 1990) .
Developmental changes in Krox-24 expression are not related to mitotic activity
The experiments that reported the initial identi®cation of the Krox-24 gene showed induction of Krox-24 mRNA in cells re-entering the cell cycle. Indeed, Krox-24 is one of the EIGs activated during proliferation of a variety of cell types in vitro (Christy and Nathans, 1989; Lemaire et al., 1988; . Given this observation, and that of the marked expression of Krox-24 in areas of the brain undergoing post natal mitosis, it was somewhat logical to examine whether Krox-24 expression and T 3 -dependent regulation were linked to mitotic activity in the developing CNS. Thus, we examined DNA synthesis in the SVZ and CB at the two time points showing distinct patterns of Krox-24 expression and T 3 -dependent regulation: P2 and P6. We found that there was no marked change in BrdU incorporation in these areas at these time points, suggesting that Krox-24 expression is not correlated to mitosis. These data corroborate those obtained by germinal transgenesis. Indeed, in an in vivo study employing homologous recombination to create Krox-24 null mice (Lee et al., 1995 (Lee et al., , 1996 , it was shown that the Krox-24 7/7 mice had no apparent changes in proliferation processes. The authors suggested that either Krox-24 had no eect on proliferation or that otherwise redundant mechanisms could enter into play. The group of P Charnay (ENS, Paris) have also described the phenotype of their homozygous Krox-24 7/7 mouse (Topilko et al., 1997) . Again, these authors saw no obvious reduction in cell proliferation (with the exception of the pituitary somatotrope population) and they showed that the small size of their Krox-24 7/7 mice could be attributed to defects in production of pituitary growth hormone (GH) (Topilko et al., 1997) . Moreover, in their conclusion where they compare results from their Krox-24
mice, in which Krox-24 mRNA and protein were completely absent, to those obtained by Lee et al. (1996) in which a part of the Krox-24 protein could still be produced, they suggest that the Krox-24 protein may be multifunctional and that the Nterminal half of the protein may control proliferation (or cell survival), at least in somatotropes.
PEI-based in vivo gene transfer is a promising tool for examining transcriptional regulation in an integrated context
A ®nal point is that PEI-based gene transfer can be used to follow transcriptional regulations in the intact mammalian CNS. Indeed, our results show that regulations followed by somatic gene transfer faithfully re¯ect endogenous gene expression, whether followed by Northern blotting or by more sophisticated germinal transgenesis with in-frame insertions of a marker gene.
Here we used PEI-based gene transfer to study a spatially and developmentally regulated process at the transcriptional level in the intact animal. This could be exploited to examine the speci®c roles of dierent receptors and accessory proteins in the transcriptional process. Indeed, it is a fair working hypothesis that the stage-dependent dierences we observe in T 3 responsiveness of the Krox-24 gene are related to developmental changes in expression of TRs and other proteins with which they interact. Developmental regulation of TRs is well documented in many species (see Forrest (1995) and above discussion), and no doubt, given the¯urry of activity in the ®eld of coactivator and co-repressor action, we will soon have data on the developmental regulations of certain members of these families.
In conclusion, we show that although T 3 exerts a positive eect on Krox-24 transcription in the early stages of neurogenesis, this eect is extinguished as development proceeds. We hypothesize that this loss of transcriptional eect is most probably related to changes in T 3 receptor pro®les and possibly of modulator proteins that interact with these receptors and other transcription factors. We propose that a suitable approach for analysing the transcriptional eects of these proteins will be PEI-based somatic gene transfer.
Materials and methods

Plasmids
Plasmids were prepared by the alkaline lysis method followed by PEG precipitation (Ausubel et al., 1994) , then resuspended in Tris-HCl pH 8, 1 mM, EDTA 0.1 mM and stocked as aliquots at 7208C.
Krox-24-luc expression vector: 1716 bp of the mouse Krox-24 5' sequence (a generous gift from Dr P Charnay, ENS, Paris) was inserted into the EcoRI/PstI sites of the pBluescriptRIII SK Vector (Stratagene, La Jolla, CA, USA). Then the fragment was cut with EcoRV/SacI and reinserted in SmaI/SacI sites of the pGL2-basic vector (Promega, Madison, WI, USA), upstream of the luciferase coding sequence.
The pcis-CMV-CAT construct contains a CMV enhancer and promoter to initiate transcription. The chloramphenicol acetyltransferase (CAT) gene was followed by the SV40 early polyadenylation sequence (Zhu et al., 1993) . The construct was kindly provided by Dr Debs, San Francisco, USA.
The CMV-LUC expression vector contains a cytomegalovirus (CMV) promoter cloned up-stream of the ®re¯y luciferase-coding region in the pGL2-basic vector (Promega, Madison, WI, USA).
The pCMV-LacZ plasmid (Clontech) has the coding sequence of the Escherichia coli lacZ gene coding for galactosidase (b-Gal) inserted downstream of the CMV promoter.
The TRE-pal-luc construct contains a synthetic oligodeoxy nucleotide sequence encoding a palindromic TRE in SVluciferase (Glass et al., 1989) . It was kindly provided by Dr C Glass, San Diego, USA.
In vitro site-directed mutagenesis
The putatif DR4 thyroid hormone response element (AGGTCCCCAAAGGTGG) was deleted from the krox-24-luc construction using GeneEditor 2 in vitro SiteDirected Mutagenesis System (Promega, Madison, WI, USA) in accordance with the manufacturer's instructions. For this a 5'-phosphorylated oligodeoxynucleotide (5'-PO 4 -CAATCAGGGT TCCGCA ATCCGATCCTCAACCGCA-GGACGGAGGG-3') composed of 20 and 24 matched bases on either side of mismatched region was used.
Treatment of animals: production of hypothyroid newborn mice
Female OF1 mice (Ia Credo, l'Abresle, France) were mated. To induce fetal and neonatal hypothyroidism, dams were given 0.05% 6-n-propyl-2-thiouracil (PTU) in drinking water at day 14 of pregnancy. PTU administration was continued throughout the lactation period. For evaluating T 3 eects on Krox-24 mRNA levels or transcription, hypothyroid or normal mice (P2 or P6) were injected with 200 mg of T 3 /100 g of body weight (in 9 0 / 00 saline) as described by Pipaon et al. (1992) . Control animals received saline (9 0 / 00 ) injections. Animals were sacri®ced 3 h after T 3 injection, and the brains were rapidly removed, dissected and frozen.
Krox-24
+/7 mutant mice Krox-24 +/7 mutant mice were a generous gift from Dr P Charnay (INSERM, ENS, Paris). In these Krox-24 +/7 heterozygous mice, one allele of Krox-24 is inactivated by the insertion of an in-frame Lac-Z gene downstream of the Krox-24 5' region using homologous recombination.
Preparation of PEI/DNA complexes
Plasmid DNA was diluted in 5% glucose to the chosen concentration (usually 0.5 ± 1 mg/ml). After vortexing, the appropriate amount of a 0.1 M PEI 22 kDa (Euromedex, Souelweyersheim, France) solution is added and the solution re-vortexed. The required amount of PEI, according to DNA concentration and number of equivalents needed, is calculated by taking into account that 1 mg DNA is 3 nmol of phosphate and that 1 ml 0.1 M PEI is 100 nmol of amine nitrogen. So, to complex 10 mg DNA (30 nmol phosphate) with 4eq PEI, one needs 120 nmol PEI (1.2 ml of a 0.1 M solution).
In vivo gene transfer
Pups were used for injections on P1 or P5. Prior to making an intracranial injection, neonatal pups were anesthetized by hypothermia on ice. The pups heads were held by hand and a small incision was made with the tips of iris scissors through the skin overlying the sagittal suture to expose the skull. A small hole was made through the skull approximately 1 ± 1.15 mm lateral to the sagittal suture. A glass micropipette attached to a micromanipulator (Narashige, Japan) was lowered approximately 1.5 ± 2 mm through the incision and 2 ml of a 5% glucose solution containing plasmids/PEI 22 kDa complexes were injected bilaterally into either the subventricular zone or the cerebellum. The solution was injected over the course of 1 ± 2 min and the pipette left in place for a further 1 ± 2 min before removal to limit diusion away from the site of release due to back¯ow pressure. Following injections pups were kept under an infrared heat lamp until active and then returned to the dam.
After an interval of 17 h, mice were anesthetized and decapitated. The SVZ and the CB were removed and used for analysis of luciferase and CAT activities. Animals that were treated with T 3 received subcutaneous injections (see above for amounts of T 3 and volumes) 3 h prior to sacri®ce. Controls received the same volume of saline at the same time point.
Radioimmunoassay of T 4 and T 3 hormones
The radioimmunoassay (RIA) dosages of plasmatic T 4 and T 3 hormones were carried out on gel Sephadex columns G25 as previously described (Demeneix and Henderson, 1978) .
b-galactosidase histochemistry
Pups were decapitated and the brains ®xed in toto (overnight, 48C; 2% paraformaldehyde, pH 7.4 in 0.1 mM PBS, supplemented with 2 mM MgCl 2 and 1.25 mM EGTA). Brains were vibratome sectioned (100 mm), then sections were immersed 3 h (338C) in b-Gal revelation solution containing 1 mg/ml X-Gal ({5-bromo-4} chloro-3-indolyl-b-D-galactoside), 0.01% Tween-20, 4 mM potassium ferrocyanide, 4 mM potassium ferricyanide, and 2 mM MgCl 2 in PBS (pH 7.3), and ®nally were mounted. A blue precipitate was seen in brains of b-gal heterozygous mice. No staining was seen in brains of non transgenic mice.
Luciferase assay
The luciferase assay was performed according to the standard protocol (luciferase assay system, Promega) in a single-well luminometer (ILA911, MGM Instruments, Hamden, CT, USA). Luciferase was estimated during 10 s with 50 ml of brain extract. The light emitted by the reaction was expressed as relative light units (RLU).
CAT enzyme assay
Assays were performed according to Seed and Sheen (1988) with slight modi®cation. The homogenate was microcentrifuged for 10 min at 48C (11 000 g). The supernatant was removed, and aliquots (50 ml) were transferred to Eppendorf tubes containing 40 ml of 0.25 M Tris-HCl buer (pH 7.5). The reaction was started by adding 10 ml of a solution of butyryl-CoA (0.53 mM; Sigma) and [ 14 C]chloramphenicol (0.01 mM, 1.85 kBq per tube; Amersham). The mixture was incubated at 378C for 1 h and the butyrylated forms of [ 14 C]chloramphenicol were extracted after centrifugation at 48C (11 000 g) by addition of 2 volumes of 2,6,10,14-tetramethylpentadecane/xylene, 2 : 1 (Aldrich). The supernatant (150 ml) was removed and the products were quanti®ed in a scintillation counter (LKB).
Total RNA preparation and Northern blot analysis
Total RNA was prepared using RNA Plus 2 reagent in accordance with the manufacturer's instructions (BIO-PROBE 1 Systems, Montreuil, France). RNA samples (40 mg) were denatured, electrophoresed on 1% formaldehyde/agarose gels and transferred to a Hybond nylon membrane (Amersham Life Sciences, Buckinghamshire, UK). The probe for Krox-24 was prepared with the 0.7 kb EcoRI/BamHI fragment from the mouse Krox-24 cDNA. The probe for b-actin was prepared with the 1 kb EcoRI/BamHI fragment from the mouse b-actin cDNA. The cDNA probes were labeled with a 32 PdCTP using a random-primer DNA-labeling kit (Rediprime, Amersham Life Sciences, Buckinghamshire, UK). Hybridization (1.6610 6 c.p.m./ml) was done overnight at 428C (50% formamide, 56SSPE, 56Denhart, 0.5% SDS) (16SSPE is 0.18 M NaCl, 10 mM NaH2PO4, pH 7.4, 10 mM EDTA, pH 7.4). Filters were washed (at high stringency conditions) twice in 26SSPE, 0.1% SDS at room temperature (RT) for 20 min, once in 0.16SSPE, 0.1% SDS at RT for 20 min, then once in 0.16SSPE, 0.1% SDS at 608C for 20 min. Signals were scanned and quantitated by computer-assisted PhosphorImager (Molecular Dynamics, Sunnyvale, CA, USA). Fold induction was calculated after normalization of the hybridization signal with respect to that for b-actin.
BrdU immunocytochemistry
Newborn mice were injected intraperitoneally (6 mg/ 100g b.wt. dissolved in PBS) with 5-bromo-2'-deoxyuridine (BrdU; Boehringer Mannheim). BrdU is a thymidine analog that is incorporated into the DNA of dividing cells during S phase and can be visualized by immunocytochemistry. Animals were killed 1 h after BrdU injection and transcardially perfused with 0.9% NaCl. The brains were removed and ®xed 3 h in Clark solution (ethanol/acetic acid, 3 : 1, v/v) then rinsed with PBS. Brains were dehydrated, paran embedded, microtome sectioned (10 mm) and mounted on slides. Sections were incubated in 1 M HCl for 20 min at 408C to denature the DNA. This was followed by 2615 min washes in 0.1 M PBS, pH 7.4, containing 1% normal goat serum and 0.3 Triton X-100. Immunocytochemistry was performed using a monoclonal mouse anti-BrdU antibody (Dako, diluted 1 : 50) and the DAKO Envision 2 + System, Peroxidase, Mouse, DAB (3,3'-diaminobenzidine tetrahydrochloride) in accordance with the manufacturers' instructions (Dako, Carpinteria, CA, USA).
Statistical analysis of results
In vivo gene transfer results are expressed as luciferase activity (relative light units: RLU) normalized against the CAT activity (c.p.m.) in the same sample. Means+s.e.m. are given. After ANOVA analysis where appropriate, Student's t-test was used to analyse dierences between groups. Dierences were considered signi®cant when P50.05.
